poisar

Stock

Veracyte, Inc. VCYT

$45.28+2.26%

Overview

VCYT market data

Price History

VCYT price chart · 1M
O
44.31
H
45.49
L
44.31
C
45.28
Vol
83,860.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$44.31
Previous Close
$44.28
Day High
$45.49
Day Low
$44.31
52 Week High
$60.77
52 Week Low
$31.17
7 Day Return
+8.46%
30 Day Return
-18.56%
90 Day Return
-2.33%
1 Year Return
+42.48%
Daily Notional Volume
$3.8M
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
29.24
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
$0.82
Diluted earnings per share over the trailing twelve months.
Beta
1.98
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
20.4%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$28.25 – $60.91
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $3.3B · P/B 2.54 · P/S 5.96.

Company News

10 captured
Top 3 Health Care Stocks That Could Blast Off This MonthBenzinga · Aug 19, 2026, 10:30 AM
Piper Sandler Maintains Overweight on Veracyte, Lowers Price Target to $54Benzinga · Aug 4, 2026, 2:41 PM
Stephens & Co. Maintains Overweight on Veracyte, Lowers Price Target to $55Benzinga · Aug 4, 2026, 1:07 PM
Morgan Stanley Maintains Underweight on Veracyte, Lowers Price Target to $44Benzinga · Aug 4, 2026, 12:42 PM
Canaccord Genuity Maintains Hold on Veracyte, Lowers Price Target to $50Benzinga · Aug 3, 2026, 9:29 PM
Apple, Stryker, Coinbase And Other Big Stocks Moving Lower In Friday’s Pre-Market SessionBenzinga · Jul 31, 2026, 12:02 PM
Needham Maintains Buy on Veracyte, Raises Price Target to $69Benzinga · Jul 31, 2026, 9:45 AM
8-K filing — VERACYTE, INC. (VCYT)SEC EDGAR · Jul 30, 2026, 8:18 PM
Veracyte Raises FY2026 Sales Guidance from $582.000M-$592.000M to $590.000M-$596.000M vs $586.445M EstBenzinga · Jul 30, 2026, 8:06 PM
Veracyte Q2 Adj. EPS $0.54 Beats $0.24 Estimate, Sales $150.321M Beat $144.554M EstimateBenzinga · Jul 30, 2026, 8:05 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock